OncoMed Pharmaceuticals Inc (NASDAQ:OMED)

2.16
Delayed Data
As of Feb 23
 0.00 / 0.00%
Today’s Change
1.74
Today|||52-Week Range
10.89
-47.32%
Year-to-Date
No recent news for OncoMed Pharmaceuticals Inc.

Today’s Trading

Previous close2.16
Today’s open2.19
Day’s range2.05 - 2.20
Volume122,141
Average volume (3 months)208,050
Market cap$81.8M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)-10.56%
Earnings growth (this year)+48.67%
Earnings growth (next 5 years)--
Revenue growth (last year)-2.88%
P/E ratioNM
Price/Sales10.07
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SBPHSpring Bank Pharmace...+0.13+1.09%
MNOVMediciNova Inc+0.29+2.73%
CKPTCheckpoint Therapeut...-0.15-3.19%
OCULOcular Therapeutix I...+0.17+3.49%
Data as of 4:00pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$25.2M
Annual profit (last year)-$103.1M
Net profit margin-409.90%

Profile

Sector
Health Technology
Industry
Biotechnology
CFO, EV President-Corporate Development &
Finance
Sunil Patel
Co-Chief Scientific Officer &
SVP-Cellular Biology
Austin Gurney
Corporate headquarters
Redwood City, California

Forecasts